Keywords: Aplastic anemia; Eltrombopag; Immunosuppressive therapy; Antithymocyte globulin; Cyclosporine; Bone marrow failure;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Eltrombopag; rituximab; romiplostim; thrombocytopenia; thrombopoietin;
Keywords: Eltrombopag; Thrombocytopenia; Hematopoietic cell transplantation; Prolonged isolated thrombocytopenia; Secondary failure of platelet recovery
Keywords: Eltrombopag; Leukemia; rHuMGDF; Romiplostim; Thrombopoietin; Supportive care; TPO; MDS;
Keywords: Eltrombopag; Meta-analysis; Randomized controlled trials; Romiplostim; Thromboembolism; Thrombosis; ThrombocytopeniaEltrombopag; Ensayo clínico aleatorizado controlado; Romiplostim; Trombocitopenia; Tromboembolismo; Trombosis; Trombopoyetina
Keywords: Eltrombopag; Meta-analysis; Randomized controlled trials; Romiplostim; Thromboembolism; Thrombosis; ThrombocytopeniaEltrombopag; Ensayo clínico aleatorizado controlado; Romiplostim; Trombocitopenia; Tromboembolismo; Trombosis; Trombopoyetina
Keywords: Chinese; eltrombopag; immune thrombocytopenia; platelet count; population pharmacokinetics/pharmacodynamics;
Keywords: AIHA; autoimmune hemolytic anemia; ASH; American Society of Hematology; CLL; chronic lymphocytic leukemia; CMV; cytomegalovirus; CVID; common variable immunodeficiency; GPRD; General Practice Research Database; DIC; disseminated intravascular coagulation;
Keywords: Immune thrombocytopenia; Rituximab; Eltrombopag; Romiplostim; Splenectomy; Thrombosis
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A
Keywords: Immunosuppressive treatment; Antithymocyte globulin; Ciclosporine A; Eltrombopag; Somatic mutations;
Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation
Keywords: Pure red blood cell aplasia; Eltrombopag; Unilineage cytopenias;
Article originalThromboses sous agonistes du récepteur de la thrombopoïétine au cours du purpura thrombopénique immunologique. Ãtude rétrospective multicentrique en FranceThrombosis during thrombopoietin receptor agonist treatment for immune thrombo
Keywords: Thrombopénie immunologique; Thromboses; Agoniste du récepteur de la thrombopoïétine; Romiplostim; Eltrombopag; Immune thrombocytopenia; Thrombosis; Thrombopoietin receptor agonist; Romiplostim; Eltrombopag;
Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales
Keywords: chronic immune thrombocytopenia; cost-effectiveness; eltrombopag; indirect treatment comparison; romiplostim; thrombopoietin receptor agonist;
THPO–MPL pathway and bone marrow failure
Keywords: THPO (Thrombopoietin); MPL (myeloproliferative leukemia virus); JAK (Janus Kinase); CALR (calreticulin); Aplastic anemia; Bone marrow failure; Thrombocythemia; Myelofibrosis; Eltrombopag; Romiplostim
Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009–2013 French PharmacoVigilance assessment
Keywords: Thrombopoietin receptor agonist; Romiplostim; Eltrombopag; Adverse drug reaction; Pharmacovigilance; Disproportionality analysis
The new thrombopoietic agenda: Impact on leukemias and MDS
Keywords: thrombopoeitin receptor agonists; romiplostim; eltrombopag; myelodysplastic syndromes; MDS; acute myeloid leukemia; AML; immune thrombocytopenia; ITP; TPO
Liquid chromatography–tandem mass spectrometric assay for eltrombopag in 50 μL of human plasma: A pharmacokinetic study
Keywords: Eltrombopag; Human plasma; Protein precipitation (PP); LC–MS/MS; Pharmacokinetics
TGFβ1 and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP
Keywords: ITP; sCTLA-4; TGFβ1; Eltrombopag; Immune tolerance
Alteraciones de la hemostasia primaria. Púrpuras y alteraciones de las plaquetas
Keywords: Plaquetas; Púrpura; Hemorragia cutaneomucosa; Trombopenia; Trombopatía; Romiplostin; EltrombopagPlatelets; Purpura; Mucocutaneous hemorrhage; Thrombopenia; Thrombopathy; Romiplostin; Eltrombopag
Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomized controlled trials
Keywords: Eltrombopag; Meta-analysis; Randomized controlled trials; Romiplostim; Thromboembolism; Thrombosis; ThrombocytopeniaEltrombopag; Metaanálisis; Ensayo clínico aleatorizado y controlado; Romiplostim; Tromboembolia; Trombosis; Trombocitopenia
A Randomized, Open-Label, 5-Period, Balanced Crossover Study to Evaluate the Relative Bioavailability of Eltrombopag Powder for Oral Suspension (PfOS) and Tablet Formulations and the Effect of a High-Calcium Meal on Eltrombopag Pharmacokinetics When Admin
Keywords: bioavailability; chelation; powder for oral suspension; eltrombopag; food; pharmacokinetics
Pharmacological profile of AS1670542, a novel orally-active human thrombopoietin receptor agonist
Keywords: Thrombopoietin; TPO receptor; Megakaryocyte; NOD/SCID mice; AS1670542; Eltrombopag
Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on megakaryopoiesis of patients with lower risk myelodysplastic syndrome
Keywords: Myelodysplastic syndrome; Megakaryopoiesis; Eltrombopag; Thrombocytopenia; Thrombopoietin
Thrombopoietic agents
Keywords: ITP, immune thrombocytopenic purpura; TPO, thrombopoietinThrombopoietin; Thrombopoietin receptor agonists; Romiplostim; Eltrombopag; Thrombocytopenia